Andrew Huberman· PhD
and I think even beyond that just now that the pharmaceutical industry is reinvigorated to investigate this question there's so many different people are going in five years people have so many different options it won't just be OIC or mro there will be five different 10 different drugs that they can choose from um that have slightly different side effect profile slightly different efficacy perhaps used for people with slightly different metabolic conditions